# LEMAITRE VASCULAR, INC. (LMAT) FY2026 Q2 Balance Sheet

- Company: LEMAITRE VASCULAR, INC. (LMAT)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-05, accession number 0001193125-26-333762
- Page: https://plicit.ai/financials/lmat/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/lmat-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 640,549,000 US dollars
- **Current assets**: 488,297,000 US dollars
- **Non-current assets**: 152,252,000 US dollars
- **Liabilities**: 220,207,000 US dollars
- **Current liabilities**: 29,935,000 US dollars
- **Non-current liabilities**: 190,272,000 US dollars
- **Equity**: 420,342,000 US dollars
- **Short-term marketable securities**: 349,615,000 US dollars
- **Inventory and other deferred costs**: 70,503,000 US dollars
- **Accounts receivable, net of allowances of $1,327 at June 30, 2026 and $1,400 at December 31, 2025**: 35,682,000 US dollars
- **Cash and cash equivalents**: 26,625,000 US dollars
- **Prepaid expenses and other current assets**: 5,872,000 US dollars
- **Goodwill**: 65,945,000 US dollars
- **Other intangibles, net**: 30,544,000 US dollars
- **Property and equipment, net**: 29,591,000 US dollars
- **Right-of-use leased assets**: 19,998,000 US dollars
- **Other assets**: 5,440,000 US dollars
- **Deferred tax assets**: 734,000 US dollars
- **Accrued expenses**: 22,880,000 US dollars
- **Lease liabilities - short-term**: 3,439,000 US dollars
- **Accounts payable**: 3,236,000 US dollars
- **Acquisition-related obligations**: 380,000 US dollars
- **Convertible senior notes, net**: 169,091,000 US dollars
- **Lease liabilities - long-term**: 17,724,000 US dollars
- **Deferred tax liabilities**: 1,998,000 US dollars
- **Other long-term liabilities**: 1,459,000 US dollars
- **Additional paid-in capital**: 236,161,000 US dollars
- **Retained earnings**: 206,017,000 US dollars
- **Common stock, $0.01 par value; 37,000,000 shares authorized, 24,494,202 and 24,396,904 shares issued, 22,864,935 and 22,772,607 shares outstanding, respectively**: 245,000 US dollars
- **Preferred stock, $0.01 par value; 3,000,000 shares authorized; none issued and outstanding**: 0 US dollars
- **Treasury stock, at cost; 1,629,267 and 1,624,297 shares, respectively**: negative 17,916,000 US dollars
- **Accumulated other comprehensive loss**: negative 4,165,000 US dollars
- **Gross equity (calculated)**: 442,423,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.